Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Reproductive Biology and Endocrinology
Published in: Reproductive Biology and Endocrinology 1/2015

Open Access 01-12-2015 | Review

Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies

Authors: Bassem Refaat, Elizabeth Dalton, William L Ledger

Published in: Reproductive Biology and Endocrinology | Issue 1/2015

Login to get access

Abstract

Background

Ectopic pregnancy (EP) is the leading cause of maternal morbidity and mortality during the first trimester and the incidence increases dramatically with in vitro fertilisation and embryo transfer (IVF-ET). The co-existence of an EP with a viable intrauterine pregnancy (IUP) is known as heterotopic pregnancy (HP) affecting about 1% of patients during assisted conception. EP/HP can cause significant morbidity and occasional mortality and represent diagnostic and therapeutic challenges, particularly during fertility treatment. Many risk factors related to IVF-ET techniques and the cause of infertility have been documented. The combination of transvaginal ultrasound (TVS) and serum human chorionic gonadotrophin (hCG) is the most reliable diagnostic tool, with early diagnosis of EP/HP permitting conservative management. This review describes the risk factors, diagnostic modalities and treatment approaches of EP/HP during IVF-ET and also their impact on subsequent fertility treatment.

Methods

The scientific literature was searched for studies investigating EP/HP during IVF-ET. Publications in English and within the past 6 years were mostly selected.

Results

A history of tubal infertility, pelvic inflammatory disease and specific aspects of embryo transfer technique are the most significant risk factors for later EP. Early measurement of serum hCG and performance of TVS by an expert operator as early as gestational week 5 can identify cases of possible EP. These women should be closely monitored with repeated ultrasound and hCG measurement until a diagnosis is reached. Treatment must be customised to the clinical condition and future fertility requirements of the patient. In cases of HP, the viable IUP can be preserved in the majority of cases but requires early detection of HP. No apparent negative impact of the different treatment approaches for EP/HP on subsequent IVF-ET, except for risk of recurrence.

Conclusions

EP/HP are tragic events in a couple’s reproductive life, and the earlier the diagnosis the better the prognosis. Due to the increase incidence following IVF-ET, there is a compelling need to develop a diagnostic biomarker/algorithm that can predict pregnancy outcome with high sensitivity and specificity before IVF-ET to prevent and/or properly manage those who are at higher risk of EP/HP.
Literature
1.
Shaw JL, Diamandis EP, Horne AW, Barnhart K, Bourne T, Messinis IE. Ectopic pregnancy. Clin Chem. 2012;58:1278–85.PubMed
2.
Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066–74.PubMed
3.
Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med. 2012;9, e1001356.PubMedCentralPubMed
4.
Jurkovic D, Wilkinson H. Diagnosis and management of ectopic pregnancy. BMJ. 2011;342:d3397.PubMed
5.
Sivalingam VN, Duncan WC, Kirk E, Shephard LA, Horne AW. Diagnosis and management of ectopic pregnancy. J Fam Plann Reprod Health Care. 2011;37:231–40.PubMedCentralPubMed
6.
Chang HJ, Suh CS. Ectopic pregnancy after assisted reproductive technology: what are the risk factors? Curr Opin Obstet Gynecol. 2010;22:202–7.PubMed
7.
Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet. 1978;2:366.PubMed
8.
Myers ER, McCrory DC, Mills AA, Price TM, Swamy GK, Tantibhedhyangkul J, et al. Effectiveness of assisted reproductive technology (ART). Evid Rep Technol Assess (Full Rep). 2008; (167): 1–195.
9.
Clayton HB, Schieve LA, Peterson HB, Jamieson DJ, Reynolds MA, Wright VC. Ectopic pregnancy risk with assisted reproductive technology procedures. Obstet Gynecol. 2006;107:595–604.PubMed
10.
Wang LL, Chen X, Ye DS, Liu YD, He YX, Guo W, et al. Misdiagnosis and delayed diagnosis for ectopic and heterotopic pregnancies after in vitro fertilization and embryo transfer. J Huazhong Univ Sci Technolog Med Sci. 2014;34:103–7.PubMed
11.
Horne AW, Critchley HO. Mechanisms of disease: the endocrinology of ectopic pregnancy. Expert Rev Mol Med. 2012;14, e7.PubMed
12.
Krishnan T, Winship A, Sonderegger S, Menkhorst E, Horne AW, Brown J, et al. The role of leukemia inhibitory factor in tubal ectopic pregnancy. Placenta. 2013;34:1014–9.PubMed
13.
Shaw JL, Dey SK, Critchley HO, Horne AW. Current knowledge of the aetiology of human tubal ectopic pregnancy. Hum Reprod Update. 2010;16:432–44.PubMedCentralPubMed
14.
Refaat B. Role of activins in embryo implantation and diagnosis of ectopic pregnancy: a review. Reprod Biol Endocrinol. 2014;12:116.PubMedCentralPubMed
15.
Refaat B, Simpson H, Britton E, Biswas J, Wells M, Aplin JD, et al. Why does the fallopian tube fail in ectopic pregnancy? The role of activins, inducible nitric oxide synthase, and MUC1 in ectopic implantation. Fertil Steril. 2012;97:1115–23.PubMed
16.
Revel A, Ophir I, Koler M, Achache H, Prus D. Changing etiology of tubal pregnancy following IVF. Hum Reprod. 2008;23:1372–6.PubMed
17.
Shao R, Nutu M, Weijdegard B, Egecioglu E, Fernandez-Rodriguez J, Karlsson-Lindahl L, et al. Clomiphene citrate causes aberrant tubal apoptosis and estrogen receptor activation in rat fallopian tube: implications for tubal ectopic pregnancy. Biol Reprod. 2009;80:1262–71.PubMed
18.
Jia-Rong Z, Shuang-Di L, Xiao-Ping W. Eutopic or ectopic pregnancy: a competition between signals derived from the endometrium and the fallopian tube for blastocyst implantation. Placenta. 2009;30:835–9.PubMed
19.
Grady R, Alavi N, Vale R, Khandwala M, McDonald SD. Elective single embryo transfer and perinatal outcomes: a systematic review and meta-analysis. Fertil Steril. 2012;97:324–31.PubMed
20.
21.
Parashi S, Moukhah S, Ashrafi M. Main risk factors for ectopic pregnancy: a case–control study in a sample of Iranian women. Int J Fertil Steril. 2014;8:147–54.PubMedCentralPubMed
22.
Rana P, Kazmi I, Singh R, Afzal M, Al-Abbasi FA, Aseeri A, et al. Ectopic pregnancy: a review. Arch Gynecol Obstet. 2013;288:747–57.PubMed
23.
Malak M, Tawfeeq T, Holzer H, Tulandi T. Risk factors for ectopic pregnancy after in vitro fertilization treatment. J Obstet Gynaecol Can. 2011;33:617–9.PubMed
24.
Weigert M, Gruber D, Pernicka E, Bauer P, Feichtinger W. Previous tubal ectopic pregnancy raises the incidence of repeated ectopic pregnancies in in vitro fertilization-embryo transfer patients. J Assist Reprod Genet. 2009;26:13–7.PubMedCentralPubMed
25.
Li C, Meng CX, Zhao WH, Lu HQ, Shi W, Zhang J. Risk factors for ectopic pregnancy in women with planned pregnancy: a case–control study. Eur J Obstet Gynecol Reprod Biol. 2014;181:176–82.PubMed
26.
Kazandi M, Turan V. Ectopic pregnancy; risk factors and comparison of intervention success rates in tubal ectopic pregnancy. Clin Exp Obstet Gynecol. 2011;38:67–70.PubMed
27.
Akande V, Turner C, Horner P, Horne A, Pacey A. Impact of Chlamydia trachomatis in the reproductive setting: British Fertility Society Guidelines for practice. Hum Fertil (Camb). 2010;13:115–25.
28.
Gradison M. Pelvic inflammatory disease. Am Fam Physician. 2012;85:791–6.PubMed
29.
Mitchell C, Prabhu M. Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment. Infect Dis Clin North Am. 2013;27:793–809.PubMed
30.
Low N, Cassell JA, Spencer B, Bender N, Hilber AM, Van Bergen J, et al. Chlamydia control activities in Europe: cross-sectional survey. Eur J Public Health. 2012;22:556–61.PubMed
31.
Newby KV, Wallace LM, French DP. How do young adults perceive the risk of chlamydia infection? A qualitative study. Br J Health Psychol. 2012;17:144–54.PubMed
32.
Stephens AJ, Aubuchon M, Schust DJ. Antichlamydial antibodies, human fertility, and pregnancy wastage. Infect Dis Obstet Gynecol. 2011;2011:525182.PubMedCentralPubMed
33.
El Hakim EA, Gordon UD, Akande VA. The relationship between serum Chlamydia antibody levels and severity of disease in infertile women with tubal damage. Arch Gynecol Obstet. 2010;281:727–33.PubMed
34.
Pacchiarotti A, Sbracia M, Mohamed MA, Frega A, Espinola SM, Aragona C. Autoimmune response to Chlamydia trachomatis infection and in vitro fertilization outcome. Fertil Steril. 2009;91:946–8.PubMed
35.
Jakus S, Neuer A, Dieterle S, Bongiovanni AM, Witkin SS. Antibody to the Chlamydia trachomatis 60 kDa heat shock protein in follicular fluid and in vitro fertilization outcome. Am J Reprod Immunol. 2008;59:85–9.PubMed
36.
Risser WL, Risser JM. The incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis: a structured review. Int J STD AIDS. 2007;18:727–31.PubMed
37.
Wallace LA, Scoular A, Hart G, Reid M, Wilson P, Goldberg DJ. What is the excess risk of infertility in women after genital chlamydia infection? A systematic review of the evidence. Sex Transm Infect. 2008;84:171–5.PubMed
38.
Katz BP, Thom S, Blythe MJ, Arno JN, Caine VM, Jones RB. Fertility in adolescent women previously treated for genitourinary chlamydial infection. Adolescent and Pediartic Gynecology. 1994;7:147–52.
39.
El Hakim EA, Epee M, Draycott T, Gordon UD, Akande VA. Significance of positive Chlamydia serology in women with normal-looking Fallopian tubes. Reprod Biomed Online. 2009;19:847–51.PubMed
40.
Karaer A, Avsar FA, Batioglu S. Risk factors for ectopic pregnancy: a case–control study. Aust N Z J Obstet Gynaecol. 2006;46:521–7.PubMed
41.
Johnson N, Van Voorst S, Sowter MC, Strandell A, Mol BW. Tubal surgery before IVF. Hum Reprod Update. 2011;17:3.PubMed
42.
Na ED, Cha DH, Cho JH, Kim MK. Comparison of IVF-ET outcomes in patients with hydrosalpinx pretreated with either sclerotherapy or laparoscopic salpingectomy. Clin Exp Reprod Med. 2012;39:182–6.PubMedCentralPubMed
43.
Schippert C, Soergel P, Staboulidou I, Bassler C, Gagalick S, Hillemanns P, et al. The risk of ectopic pregnancy following tubal reconstructive microsurgery and assisted reproductive technology procedures. Arch Gynecol Obstet. 2012;285:863–71.PubMed
44.
Audebert A, Pouly JL, Bonifacie B, Yazbeck C. Laparoscopic surgery for distal tubal occlusions: lessons learned from a historical series of 434 cases. Fertil Steril. 2014;102:1203–8.PubMed
45.
Hjordt Hansen MV, Dalsgaard T, Hartwell D, Skovlund CW, Lidegaard O. Reproductive prognosis in endometriosis. A national cohort study. Acta Obstet Gynecol Scand. 2014;93:483–9.PubMed
46.
Bogdanskiene G, Berlingieri P, Grudzinskas JG. Association between ectopic pregnancy and pelvic endometriosis. Int J Gynaecol Obstet. 2006;92:157–8.PubMed
47.
Yang XJ, Xu JY, Shen ZJ, Zhao J. Immunohistochemical alterations of cajal-like type of tubal interstitial cells in women with endometriosis and tubal ectopic pregnancy. Arch Gynecol Obstet. 2013;288:1295–300.PubMed
48.
Hyland A, Piazza KM, Hovey KM, Ockene JK, Andrews CA, Rivard C, et al. Associations of lifetime active and passive smoking with spontaneous abortion, stillbirth and tubal ectopic pregnancy: a cross-sectional analysis of historical data from the Women’s Health Initiative. Tob Control. 2014; doi:10.1136/tobaccocontrol-2013-051458.
49.
Waylen AL, Metwally M, Jones GL, Wilkinson AJ, Ledger WL. Effects of cigarette smoking upon clinical outcomes of assisted reproduction: a meta-analysis. Hum Reprod Update. 2009;15:31–44.PubMed
50.
Talbot P, Riveles K. Smoking and reproduction: the oviduct as a target of cigarette smoke. Reprod Biol Endocrinol. 2005;3:52.PubMedCentralPubMed
51.
Shao R. Cigarette smoking effect on oviductal ciliation and ciliogenesis. Fertil Steril. 2013;99, e5.PubMed
52.
Shao R, Zou S, Wang X, Feng Y, Brannstrom M, Stener-Victorin E, et al. Revealing the hidden mechanisms of smoke-induced fallopian tubal implantation. Biol Reprod. 2012;86:131.PubMed
53.
Horne AW, Brown JK, Nio-Kobayashi J, Abidin HB, Adin ZE, Boswell L, et al. The association between smoking and ectopic pregnancy: why nicotine is BAD for your fallopian tube. PLoS One. 2014;9, e89400.PubMedCentralPubMed
54.
Galliano D, Bellver J, Diaz-Garcia C, Simon C, Pellicer A. ART and uterine pathology: how relevant is the maternal side for implantation? Hum Reprod Update. 2015;21:13–38.PubMed
55.
Yoshino O, Hayashi T, Osuga Y, Orisaka M, Asada H, Okuda S, et al. Decreased pregnancy rate is linked to abnormal uterine peristalsis caused by intramural fibroids. Hum Reprod. 2010;25:2475–9.PubMed
56.
Steptoe PC, Edwards RG. Reimplantation of a human embryo with subsequent tubal pregnancy. Lancet. 1976;1:880–2.PubMed
57.
Wang L, Qiao J, Li R, Zhen X, Liu Z. Role of endometrial blood flow assessment with color Doppler energy in predicting pregnancy outcome of IVF-ET cycles. Reprod Biol Endocrinol. 2010;8:122.PubMedCentralPubMed
58.
Shao R, Feng Y, Zou S, Weijdegard B, Wu G, Brannstrom M, et al. The role of estrogen in the pathophysiology of tubal ectopic pregnancy. Am J Transl Res. 2012;4:269–78.PubMedCentralPubMed
59.
Wang J, Wei Y, Diao F, Cui Y, Mao Y, Wang W, et al. The association between polycystic ovary syndrome and ectopic pregnancy after in vitro fertilization and embryo transfer. Am J Obstet Gynecol. 2013;209:139. e1-9.PubMed
60.
Allersma T, Farquhar C, Cantineau AE. Natural cycle in vitro fertilisation (IVF) for subfertile couples. Cochrane Database Syst Rev. 2013;8, CD010550.PubMed
61.
Wu Z, Li R, Ma Y, Deng B, Zhang X, Meng Y, et al. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles. Reprod Biomed Online. 2012;24:511–20.PubMed
62.
Zhang YL, Sun J, Su YC, Guo YH. and Sun YP [Study on the incidence and influences on ectopic pregnancy from embryo transfer of fresh cycles and frozen-thawed cycles]. Zhonghua Fu Chan Ke Za Zhi. 2012;47:655–8.PubMed
63.
Zhang YL, Sun J, Su YC, Guo YH, Sun YP. Ectopic pregnancy in frozen-thawed embryo transfer: a retrospective analysis of 4,034 cycles and related factors. Syst Biol Reprod Med. 2013;59:34–7.PubMed
64.
Givens CR, Markun LC, Ryan IP, Chenette PE, Herbert CM, Schriock ED. Outcomes of natural cycles versus programmed cycles for 1677 frozen-thawed embryo transfers. Reprod Biomed Online. 2009;19:380–4.PubMed
65.
Hancke K, More S, Kreienberg R, Weiss JM. Patients undergoing frozen-thawed embryo transfer have similar live birth rates in spontaneous and artificial cycles. J Assist Reprod Genet. 2012;29:403–7.PubMedCentralPubMed
66.
Shen C, Shu D, Zhao X, Gao Y. Comparison of clinical outcomes between fresh embryo transfers and frozen-thawed embryo transfers. Iran J Reprod Med. 2014;12:409–14.PubMedCentralPubMed
67.
Eftekhar M, Rahsepar M, Rahmani E. Effect of progesterone supplementation on natural frozen-thawed embryo transfer cycles: a randomized controlled trial. Int J Fertil Steril. 2013;7:13–20.PubMedCentralPubMed
68.
Stadtmauer L, Silverberg KM, Ginsburg ES, Weiss H, Howard B. Progesterone vaginal ring versus vaginal gel for luteal support with in vitro fertilization: a randomized comparative study. Fertil Steril. 2013;99:1543–9.PubMed
69.
Baker VL, Jones CA, Doody K, Foulk R, Yee B, Adamson GD, et al. A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization. Hum Reprod. 2014;29:2212–20.PubMedCentralPubMed
70.
Lockwood G, Griesinger G, Cometti B. Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study. Fertil Steril. 2014;101:112–9.PubMed
71.
Glujovsky D, Pesce R, Fiszbajn G, Sueldo C, Hart RJ, Ciapponi A. Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes. Cochrane Database Syst Rev. 2010; (1):CD006359.
72.
van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev. 2011; (10):CD009154.
73.
Kaur H, Krishna D, Shetty N, Krishnan S, Srinivas MS, Rao KA. Effect of Pre-ovulatory Single Dose GnRH agonist Therapy on IVF Outcome in GnRH Antagonist Cycles; A Prospective Study. J Reprod Infertil. 2012;13:225–31.PubMedCentralPubMed
74.
Sahin S, Ozay A, Ergin E, Turkgeldi L, Kurum E, Ozornek H. The risk of ectopic pregnancy following GnRH agonist triggering compared with hCG triggering in GnRH antagonist ivf cycles. Arch Gynecol Obstet. 2015;291:185–91.PubMed
75.
Youssef MA, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, Aboulfoutouh I, et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst Rev. 2011; (11):CD008046.
76.
Howles CM, Ezcurra D, Homburg R. Ovarian stimulation protocols in assisted reproductive technology: an update. Expert Review of Endocrinology & Metabolism. 2012;7:319–30.
77.
Jun SH, Milki AA. Assisted hatching is associated with a higher ectopic pregnancy rate. Fertil Steril. 2004;81:1701–3.PubMed
78.
Hagemann AR, Lanzendorf SE, Jungheim ES, Chang AS, Ratts VS, Odem RR. A prospective, randomized, double-blinded study of assisted hatching in women younger than 38 years undergoing in vitro fertilization. Fertil Steril. 2010;93:586–91.PubMed
79.
Karipcin FS, Moragianni VA, Milette B, Kinzer DR, Thornton KL, Barrett B, et al. Effect of steroid and antibiotic treatment during assisted hatching on IVF outcomes. Hum Fertil (Camb). 2012;15:205–9.
80.
Wang SS, Sun HX. Blastocyst transfer ameliorates live birth rate compared with cleavage-stage embryos transfer in fresh in vitro fertilization or intracytoplasmic sperm injection cycles: reviews and meta-analysis. Yonsei Med J. 2014;55:815–25.PubMedCentralPubMed
81.
Li RR, Dong YZ, Guo YH, Sun YP, Su YC, Chen F. Comparative study of pregnancy outcomes between day 3 embryo transfer and day 5 blastocyst transfer in patients with progesterone elevation. J Int Med Res. 2013;41:1318–25.PubMed
82.
Milki AA, Jun SH. Ectopic pregnancy rates with day 3 versus day 5 embryo transfer: a retrospective analysis. BMC Pregnancy Childbirth. 2003;3:7.PubMedCentralPubMed
83.
Smith LP, Oskowitz SP, Dodge LE, Hacker MR. Risk of ectopic pregnancy following day-5 embryo transfer compared with day-3 transfer. Reprod Biomed Online. 2013;27:407–13.PubMed
84.
Ishihara O, Kuwahara A, Saitoh H. Frozen-thawed blastocyst transfer reduces ectopic pregnancy risk: an analysis of single embryo transfer cycles in Japan. Fertil Steril. 2011;95:1966–9.PubMed
85.
Shapiro BS, Daneshmand ST, De Leon L, Garner FC, Aguirre M, Hudson C. Frozen-thawed embryo transfer is associated with a significantly reduced incidence of ectopic pregnancy. Fertil Steril. 2012;98:1490–4.PubMed
86.
Huang B, Hu D, Qian K, Ai J, Li Y, Jin L, et al. Is frozen embryo transfer cycle associated with a significantly lower incidence of ectopic pregnancy? An analysis of more than 30,000 cycles. Fertil Steril. 2014;102:1345–9.PubMed
87.
Job-Spira N, Coste J, Bouyer J, Tharaux-Deneux C, Fernandez H. Chromosomal abnormalities and ectopic pregnancy? New directions for aetiological research. Hum Reprod. 1996;11:239–42.PubMed
88.
Ertzeid G, Storeng R. The impact of ovarian stimulation on implantation and fetal development in mice. Hum Reprod. 2001;16:221–5.PubMed
89.
Lesny P, Killick SR, Tetlow RL, Robinson J, Maguiness SD. Embryo transfer–can we learn anything new from the observation of junctional zone contractions? Hum Reprod. 1998;13:1540–6.PubMed
90.
Lesny P, Killick SR, Tetlow RL, Robinson J, Maguiness SD. Uterine junctional zone contractions during assisted reproduction cycles. Hum Reprod Update. 1998;4:440–5.PubMed
91.
Zhu L, Xiao L, Che HS, Li YP, Liao JT. Uterine peristalsis exerts control over fluid migration after mock embryo transfer. Hum Reprod. 2014;29:279–85.PubMed
92.
Zhu L, Che HS, Xiao L, Li YP. Uterine peristalsis before embryo transfer affects the chance of clinical pregnancy in fresh and frozen-thawed embryo transfer cycles. Hum Reprod. 2014;29:1238–43.PubMed
93.
Azem F, Yaron Y, Botchan A, Amit A, Yovel I, David MP, et al. Ectopic pregnancy after in vitro fertilization-embryo transfer (IVF-ET): the possible role of the ET technique. J Assist Reprod Genet. 1993;10:302–4.PubMed
94.
Nazari A, Askari HA, Check JH, O’Shaughnessy A. Embryo transfer technique as a cause of ectopic pregnancy in in vitro fertilization. Fertil Steril. 1993;60:919–21.PubMed
95.
Keegan DA, Morelli SS, Noyes N, Flisser ED, Berkeley AS, Grifo JA. Low ectopic pregnancy rates after in vitro fertilization: do practice habits matter? Fertil Steril. 2007;88:734–6.PubMed
96.
Marcus SF, Brinsden PR. Analysis of the incidence and risk factors associated with ectopic pregnancy following in-vitro fertilization and embryo transfer. Hum Reprod. 1995;10:199–203.PubMed
97.
Knutzen V, Stratton CJ, Sher G, McNamee PI, Huang TT, Soto-Albors C. Mock embryo transfer in early luteal phase, the cycle before in vitro fertilization and embryo transfer: a descriptive study. Fertil Steril. 1992;57:156–62.PubMed
98.
Coroleu B, Barri PN, Carreras O, Martinez F, Parriego M, Hereter L, et al. The influence of the depth of embryo replacement into the uterine cavity on implantation rates after IVF: a controlled, ultrasound-guided study. Hum Reprod. 2002;17:341–6.PubMed
99.
Eytan O, Elad D, Jaffa AJ. Evaluation of the embryo transfer protocol by a laboratory model of the uterus. Fertil Steril. 2007;88:485–93.PubMed
100.
Friedman BE, Lathi RB, Henne MB, Fisher SL, Milki AA. The effect of air bubble position after blastocyst transfer on pregnancy rates in IVF cycles. Fertil Steril. 2011;95:944–7.PubMed
101.
Rovei V, Dalmasso P, Gennarelli G, Lantieri T, Basso G, Benedetto C, et al. IVF outcome is optimized when embryos are replaced between 5 and 15 mm from the fundal endometrial surface: a prospective analysis on 1184 IVF cycles. Reprod Biol Endocrinol. 2013;11:114.PubMedCentralPubMed
102.
Cenksoy PO, Ficicioglu C, Yesiladali M, Akcin OA, Kaspar C. The importance of the length of uterine cavity, the position of the tip of the inner catheter and the distance between the fundal endometrial surface and the air bubbles as determinants of the pregnancy rate in IVF cycles. Eur J Obstet Gynecol Reprod Biol. 2014;172:46–50.PubMed
103.
Pandian Z, Marjoribanks J, Ozturk O, Serour G, Bhattacharya S. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection. Cochrane Database Syst Rev. 2013;7, CD003416.PubMed
104.
Kissin DM, Kulkarni AD, Kushnir VA, Jamieson DJ. Number of embryos transferred after in vitro fertilization and good perinatal outcome. Obstet Gynecol. 2014;123:239–47.PubMed
105.
Chai J, Yeung TW, Lee VC, Li RH, Lau EY, Yeung WS, et al. Live birth rate, multiple pregnancy rate, and obstetric outcomes of elective single and double embryo transfers: Hong Kong experience. Hong Kong Med J. 2014;20:102–6.PubMed
106.
Chambers GM, Ledger W. The economic implications of multiple pregnancy following ART. Semin Fetal Neonatal Med. 2014;19:254–61.PubMed
107.
Perkins KM, Boulet SL, Kissin DM, Jamieson DJ. Risk of ectopic pregnancy associated with assisted reproductive technology in the United States, 2001–2011. Obstet Gynecol. 2015;125:70–8.PubMed
108.
Luo X, Lim CE, Huang C, Wu J, Wong WS, Cheng NC. Heterotopic pregnancy following in vitro fertilization and embryo transfer: 12 cases report. Arch Gynecol Obstet. 2009;280:325–9.PubMed
109.
Dillon KE, Sioulas VD, Sammel MD, Chung K, Takacs P, Shaunik A, et al. How and when human chorionic gonadotropin curves in women with an ectopic pregnancy mimic other outcomes: differences by race and ethnicity. Fertil Steril. 2012;98:911–6.PubMedCentralPubMed
110.
Wu G, Yang J, Xu W, Yin T, Zou Y, Wang Y. Serum beta human chorionic gonadotropin levels on day 12 after in vitro fertilization in predicting final type of clinical pregnancy. J Reprod Med. 2014;59:161–6.PubMed
111.
Kao LY, Scheinfeld MH, Chernyak V, Rozenblit AM, Oh S, Dym RJ. Beyond ultrasound: CT and MRI of ectopic pregnancy. AJR Am J Roentgenol. 2014;202:904–11.PubMed
112.
Kirk E, Bottomley C, Bourne T. Diagnosing ectopic pregnancy and current concepts in the management of pregnancy of unknown location. Hum Reprod Update. 2014;20:250–61.PubMed
113.
114.
Guha S, Ayim F, Ludlow J, Sayasneh A, Condous G, Kirk E, et al. Triaging pregnancies of unknown location: the performance of protocols based on single serum progesterone or repeated serum hCG levels. Hum Reprod. 2014;29:938–45.PubMed
115.
Shapiro BS, Daneshmand ST, Restrepo H, Garner FC. Serum HCG measured in the peri-implantation period predicts IVF cycle outcomes. Reprod Biomed Online. 2012;25:248–53.PubMed
116.
Lawler CC, Budrys NM, Rodgers AK, Holden A, Brzyski RG, Schenken RS. Serum beta human chorionic gonadotropin levels can inform outcome counseling after in vitro fertilization. Fertil Steril. 2011;96:505–7.PubMed
117.
Kathiresan AS, Cruz-Almeida Y, Barrionuevo MJ, Maxson WS, Hoffman DI, Weitzman VN, et al. Prognostic value of beta-human chorionic gonadotropin is dependent on day of embryo transfer during in vitro fertilization. Fertil Steril. 2011;96:1362–6.PubMed
118.
Zhang Q, Tang R, Gao X, Zhang B, Chen ZJ. Serum human chorionic gonadotropin level measured 17 days after oocyte retrieval can predict final clinical pregnancy outcomes in IVF/ICSI treatment cycles. J Reprod Med. 2014;59:285–92.PubMed
119.
Chen ZY, Liu JH, Liang K, Liang WX, Ma SH, Zeng GJ, et al. The diagnostic value of a multivariate logistic regression analysis model with transvaginal power Doppler ultrasonography for the prediction of ectopic pregnancy. J Int Med Res. 2012;40:184–93.PubMed
120.
Desai D, Lu J, Wyness SP, Greene DN, Olson KN, Wiley CL, et al. Human chorionic gonadotropin discriminatory zone in ectopic pregnancy: does assay harmonization matter? Fertil Steril. 2014;101:1671–4.PubMed
121.
Kirk E. Ultrasound in the diagnosis of ectopic pregnancy. Clin Obstet Gynecol. 2012;55:395–401.PubMed
122.
Talbot K, Simpson R, Price N, Jackson SR. Heterotopic pregnancy. J Obstet Gynaecol. 2011;31:7–12.PubMed
123.
Uysal F, Uysal A, Oztekin DC, Avci MS. Heterotopic quadruplet pregnancy and successful twin outcome. Arch Gynecol Obstet. 2013;288:715–7.PubMed
124.
Petrides A, Dinglas C, Chavez M, Taylor S, Mahboob S. Revisiting ectopic pregnancy: a pictorial essay. J Clin Imaging Sci. 2014;4:37.PubMedCentralPubMed
125.
Yamamoto R, Murakoshi H, Yamashita Y, Ejima Y, Yoshida S, Motoyama S. Heterotopic pregnancy diagnosed before the onset of severe symptoms: case report. Clin Exp Obstet Gynecol. 2013;40:445–7.PubMed
126.
Li XH, Ouyang Y, Lu GX. Value of transvaginal sonography in diagnosing heterotopic pregnancy after in-vitro fertilization with embryo transfer. Ultrasound Obstet Gynecol. 2013;41:563–9.PubMed
127.
Benson CB, Doubilet PM, Peters HE, Frates MC. Intrauterine fluid with ectopic pregnancy: a reappraisal. J Ultrasound Med. 2013;32:389–93.PubMed
128.
Malhotra R, Bramante RM, Radomski M, Nelson M. Mirror image artifact mimicking heterotopic pregnancy on transvaginal ultrasound: case series. West J Emerg Med. 2014;15:712–4.PubMedCentralPubMed
129.
Chojenta C, Harris S, Reilly N, Forder P, Austin MP, Loxton D. History of pregnancy loss increases the risk of mental health problems in subsequent pregnancies but not in the postpartum. PLoS One. 2014;9, e95038.PubMedCentralPubMed
130.
Bachman EA, Barnhart K. Medical management of ectopic pregnancy: a comparison of regimens. Clin Obstet Gynecol. 2012;55:440–7.PubMedCentralPubMed
131.
Oron G, Tulandi T. A pragmatic and evidence-based management of ectopic pregnancy. J Minim Invasive Gynecol. 2013;20:446–54.PubMed
132.
Pouly JL, Mahnes H, Mage G, Canis M, Bruhat MA. Conservative laparoscopic treatment of 321 ectopic pregnancies. Fertil Steril. 1986;46:1093–7.PubMed
133.
Chaudhary P, Manchanda R, Patil VN. Retrospective study on laparoscopic management of ectopic pregnancy. J Obstet Gynaecol India. 2013;63:173–6.PubMedCentralPubMed
134.
Agdi M, Tulandi T. Surgical treatment of ectopic pregnancy. Best Pract Res Clin Obstet Gynaecol. 2009;23:519–27.PubMed
135.
Mol F, Mol BW, Ankum WM, Van der Veen F, Hajenius PJ. Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis. Hum Reprod Update. 2008;14:309–19.PubMed
136.
Hajenius PJ, Mol F, Mol BW, Bossuyt PM, Ankum WM, van der Veen F. Interventions for tubal ectopic pregnancy. Cochrane Database Syst Rev. 2007; (1):CD000324.
137.
Mol F, Van Mello NM, Strandell A, Strandell K, Jurkovic D, Ross J, et al. Salpingotomy versus salpingectomy in women with tubal pregnancy (ESEP study): an open-label, multicentre, randomised controlled trial. Lancet. 2014;383:1483–9.PubMed
138.
Fernandez H, Capmas P, Lucot JP, Resch B, Panel P, Bouyer J. Fertility after ectopic pregnancy: the DEMETER randomized trial. Hum Reprod. 2013;28:1247–53.PubMed
139.
Newbatt E, Beckles Z, Ullman R, Lumsden MA. Ectopic pregnancy and miscarriage: summary of NICE guidance. BMJ. 2012;345, e8136.PubMed
140.
Van Mello NM, Mol F, Opmeer BC, De Bekker-Grob EW, Essink-Bot ML, Ankum WM, et al. Salpingotomy or salpingectomy in tubal ectopic pregnancy: what do women prefer? Reprod Biomed Online. 2010;21:687–93.PubMed
141.
Verma U, English D, Brookfield K. Conservative management of nontubal ectopic pregnancies. Fertil Steril. 2011;96:1391–5.PubMed
142.
Cohen A, Bibi G, Almog B, Tsafrir Z, Levin I. Second-dose methotrexate in ectopic pregnancies: the role of beta human chorionic gonadotropin. Fertil Steril. 2014;102:1646–9.PubMed
143.
McLaren JF, Barnhart KT, Sammel MD, Appleby DH, Butts SF. Success of the two-dose methotrexate protocol for treatment of ectopic pregnancy in women with a history of prior ectopic pregnancy. J Reprod Med. 2014;59:379–84.PubMed
144.
Yeh J, Aziz N, Chueh J. Nonsurgical management of heterotopic abdominal pregnancy. Obstet Gynecol. 2013;121:489–95.PubMed
145.
Horne AW, Skubisz MM, Tong S, Duncan WC, Neil P, Wallace EM, et al. Combination gefitinib and methotrexate treatment for non-tubal ectopic pregnancies: a case series. Hum Reprod. 2014;29:1375–9.PubMedCentralPubMed
146.
Bodur S, Ozdamar O, Kilic S, Gun I. The efficacy of the systemic methotrexate treatment in caesarean scar ectopic pregnancy: A quantitative review of English literature. J Obstet Gynaecol. 2014;1–7. doi:10.3109/01443615.2014.954101
147.
Cecchino GN, Araujo Junior E, Elito JJ. Methotrexate for ectopic pregnancy: when and how. Arch Gynecol Obstet. 2014;290:417–23.PubMed
148.
Barnhart KT, Gosman G, Ashby R, Sammel M. The medical management of ectopic pregnancy: a meta-analysis comparing “single dose” and “multidose” regimens. Obstet Gynecol. 2003;101:778–84.PubMed
149.
Epee-Bekima M, Overton C. Diagnosis and treatment of ectopic pregnancy. Practitioner. 2013;257:15–7.PubMed
150.
Cohen A, Zakar L, Gil Y, Amer-Alshiek J, Bibi G, Almog B, et al. Methotrexate success rates in progressing ectopic pregnancies: a reappraisal. Am J Obstet Gynecol. 2014;211:128. e1-5.PubMed
151.
Skubisz M, Dutton P, Duncan WC, Horne AW, Tong S. Using a decline in serum hCG between days 0–4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study. BMC Pregnancy Childbirth. 2013;13:30.PubMedCentralPubMed
152.
Addar MH. Methotrexate embryopathy in a surviving intrauterine fetus after presumed diagnosis of ectopic pregnancy: case report. J Obstet Gynaecol Can. 2004;26:1001–3.PubMed
153.
Usta IM, Nassar AH, Yunis KA, Abu-Musa AA. Methotrexate embryopathy after therapy for misdiagnosed ectopic pregnancy. Int J Gynaecol Obstet. 2007;99:253–5.PubMed
154.
Savelli L, Fabbri F, Di Donato N, De Meis L. Heterotopic interstitial pregnancy successfully treated with ultrasound-guided potassium chloride injection in the ectopic embryo. J Obstet Gynaecol. 2014;34:276–7.PubMed
155.
Ugurlucan FG, Bastu E, Dogan M, Kalelioglu I, Alanya S, Has R. Management of cesarean heterotopic pregnancy with transvaginal ultrasound-guided potassium chloride injection and gestational sac aspiration, and review of the literature. J Minim Invasive Gynecol. 2012;19:671–3.PubMed
156.
Allison JL, Aubuchon M, Leasure JD, Schust DJ. Hyperosmolar glucose injection for the treatment of heterotopic ovarian pregnancy. Obstet Gynecol. 2012;120:449–52.PubMed
157.
Timor-Tritsch IE. Hyperosmolar glucose injection for the treatment of heterotopic ovarian pregnancy. Obstet Gynecol. 2012;120:1212. author reply 1212–3.PubMed
158.
Wang Y, Ma CH, Qiao J, Chen XN, Liu P. Efficacy of local aspiration in the conservative treatment of live interstitial pregnancy coexisting with live intrauterine pregnancy after in vitro fertilization and embryo transfer. Chin Med J (Engl). 2012;125:1345–8.
159.
Skubisz MM, Horne AW, Johns TG, Nilsson UW, Duncan WC, Wallace EM, et al. Combination gefitinib and methotrexate compared with methotrexate alone to treat ectopic pregnancy. Obstet Gynecol. 2013;122:745–51.PubMed
160.
Tong S, Skubisz MM, Horne AW. Molecular diagnostics and therapeutics for ectopic pregnancy. Mol Hum Reprod. 2015;21:126–35.PubMed
161.
Rodrigues SP, De Burlet KJ, Hiemstra E, Twijnstra AR, Van Zwet EW, Trimbos-Kemper TC, et al. Ectopic pregnancy: when is expectant management safe? Gynecol Surg. 2012;9:421–6.PubMedCentralPubMed
162.
Mavrelos D, Nicks H, Jamil A, Hoo W, Jauniaux E, Jurkovic D. Efficacy and safety of a clinical protocol for expectant management of selected women diagnosed with a tubal ectopic pregnancy. Ultrasound Obstet Gynecol. 2013;42:102–7.PubMed
163.
Kirk E, Bourne T. Predicting outcomes in pregnancies of unknown location. Womens Health (Lond Engl). 2008;4:491–9.
164.
Kirk E, Van Calster B, Condous G, Papageorghiou AT, Gevaert O, Van Huffel S, et al. Ectopic pregnancy: using the hCG ratio to select women for expectant or medical management. Acta Obstet Gynecol Scand. 2011;90:264–72.PubMed
165.
Van Mello NM, Mol F, Verhoeve HR, Van Wely M, Adriaanse AH, Boss EA, et al. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison. Hum Reprod. 2013;28:60–7.PubMed
166.
Casikar I, Lu C, Reid S, Bignardi T, Mongelli M, Morris A, et al. Methotrexate vs placebo in early tubal ectopic pregnancy: a multi- centre double-blind randomised trial. Rev Recent Clin Trials. 2012;7:238–43.PubMed
167.
Daponte A, Deligeoroglou E, Garas A, Pournaras S, Hadjichristodoulou C, Messinis IE. Activin A and follistatin as biomarkers for ectopic pregnancy and missed abortion. Dis Markers. 2013;35:497–503.PubMedCentralPubMed
168.
Kirk E, Papageorghiou AT, Van Calster B, Condous G, Cowans N, Van Huffel S, et al. The use of serum inhibin A and activin A levels in predicting the outcome of ‘pregnancies of unknown location’. Hum Reprod. 2009;24:2451–6.PubMed
169.
Litwicka K, Greco E. Caesarean scar pregnancy: a review of management options. Curr Opin Obstet Gynecol. 2013;25:456–61.PubMed
170.
Fisher SL, Massie JA, Blumenfeld YJ, Lathi RB. Sextuplet heterotopic pregnancy presenting as ovarian hyperstimulation syndrome and hemoperitoneum. Fertil Steril. 2011;95:2431. e1-3.PubMed
171.
Kumbak B, Ozkan ZS, Simsek M. Heterotopic pregnancy following bilateral tubal ligation: case report. Eur J Contracept Reprod Health Care. 2011;16:319–21.PubMed
172.
Fukuda T, Inoue H, Toyama Y, Ichida T, Uzawa Y, Monma M, et al. Bilateral tubal and intrauterine pregnancies diagnosed at laparoscopy. J Obstet Gynaecol Res. 2014;40:2114–7.PubMed
173.
Yu Y, Xu W, Xie Z, Huang Q, Li S. Management and outcome of 25 heterotopic pregnancies in Zhejiang, China. Eur J Obstet Gynecol Reprod Biol. 2014;180:157–61.PubMed
174.
Gibson KR, Horne AW. Ruptured heterotopic pregnancy: an unusual presentation of an uncommon clinical problem. BMJ Case Rep. 2012; 2012: bcr2012007423. doi:10.1136/bcr-2012-007423.
175.
Park HR, Moon MJ, Ahn EH, Baek MJ, Choi DH. Heterotopic quadruplet pregnancy: conservative management with ultrasonographically-guided KCl injection of cornual pregnancy and laparoscopic operation of tubal pregnancy. Fetal Diagn Ther. 2009;26:227–30.PubMed
176.
Ghazeeri GS, Phillips OP, Emerson DS, Kutteh WH, Ke RW. Live birth after treatment of a heterotopic cornual pregnancy with fetal intrathoracic KCI. A case report. J Reprod Med. 2002;47:1038–40.PubMed
177.
Qin L, Li S, Tan S. Laparoscopic loop ligature for selective therapy in heterotopic interstitial and intrauterine pregnancy following in-vitro fertilization and embryo transfer. Int J Gynaecol Obstet. 2008;101:80–1.PubMed
178.
Aust T, O’Neill A, Cario G. Purse-string suture technique to enable laparoscopic management of the interstitial gestation of a heterotopic pregnancy. Fertil Steril. 2011;95:261–3.PubMed
179.
Eom JM, Choi JS, Ko JH, Lee JH, Park SH, Hong JH, et al. Surgical and obstetric outcomes of laparoscopic management for women with heterotopic pregnancy. J Obstet Gynaecol Res. 2013;39:1580–6.PubMed
180.
Alvarez M, Sole M, Devesa M, Fabregas R, Boada M, Tur R, et al. Live birth using vitrified–warmed oocytes in invasive ovarian cancer: case report and literature review. Reprod Biomed Online. 2014;28:663–8.PubMed
181.
Sentilhes L, Bouet PE, Gromez A, Poilblanc M, Lefebvre-Lacoeuille C, Descamps P. Successful expectant management for a cornual heterotopic pregnancy. Fertil Steril. 2009;91:934. e11-3.
182.
Baxi A, Kaushal M, Karmalkar H, Sahu P, Kadhi P, Daval B. Successful expectant management of tubal heterotopic pregnancy. J Hum Reprod Sci. 2010;3:108–10.PubMedCentralPubMed
183.
OuYang Z, Yin Q, Xu Y, Ma Y, Zhang Q, Yu Y. Heterotopic Cesarean Scar Pregnancy: Diagnosis, Treatment, and Prognosis. J Ultrasound Med. 2014;33:1533–7.PubMed
184.
Litwicka K, Greco E, Prefumo F, Fratelli N, Scarselli F, Ferrero S, et al. Successful management of a triplet heterotopic caesarean scar pregnancy after in vitro fertilization-embryo transfer. Fertil Steril. 2011;95:291. e1-3.PubMed
185.
Singh K, Soni A, Rana S. Ruptured ectopic pregnancy in caesarean section scar: a case report. Case Rep Obstet Gynecol. 2012;2012:106892.PubMedCentralPubMed
186.
Cho JH, Kwon H, Lee KW, Han WB. Cervical heterotopic pregnancy after assisted reproductive technology successfully treated with only simple embryo aspiration: a case report. J Reprod Med. 2007;52:250–2.PubMed
187.
Prorocic M, Vasiljevic M. Treatment of heterotopic cervical pregnancy after in vitro fertilization-embryo transfer by using transvaginal ultrasound-guided aspiration and instillation of hypertonic solution of sodium chloride. Fertil Steril. 2007;88:969. e3-5.PubMed
188.
Kim JW, Park HM, Lee WS, Yoon TK. What is the best treatment of heterotopic cervical pregnancies for a successful pregnancy outcome? Clin Exp Reprod Med. 2012;39:187–92.PubMedCentralPubMed
189.
Demirel LC, Bodur H, Selam B, Lembet A, Ergin T. Laparoscopic management of heterotopic cesarean scar pregnancy with preservation of intrauterine gestation and delivery at term: case report. Fertil Steril. 2009;91:1293. e5-7.PubMed
190.
Wang CJ, Tsai F, Chen C, Chao A. Hysteroscopic management of heterotopic cesarean scar pregnancy. Fertil Steril. 2010;94:1529. e15-8.PubMed
191.
Kamath MS, Aleyamma TK, Muthukumar K, Kumar RM, George K. A rare case report: ovarian heterotopic pregnancy after in vitro fertilization. Fertil Steril. 1910;2010(94):e9–11.
192.
Headley AJ, Adum V. Naturally occurring heterotopic pregnancy in a multiparous patient: a case report. J Reprod Med. 2013;58:541–4.PubMed
193.
Nathorst-Boos J, Hamad R. Risk factors for persistent trophoblastic activity after surgery for ectopic pregnancy. Acta Obstet Gynecol Scand. 2004;83:471–5.PubMed
194.
Bora SA, Kirk E, Daemen A, Timmerman D, Bourne T. Is serum human chorionic gonadotrophin follow-up necessary after suspected spillage of trophoblast at the time of laparoscopic surgery for ectopic pregnancy? Gynecol Obstet Invest. 2011;71:225–8.PubMed
195.
Clayton HB, Schieve LA, Peterson HB, Jamieson DJ, Reynolds MA, Wright VC. A comparison of heterotopic and intrauterine-only pregnancy outcomes after assisted reproductive technologies in the United States from 1999 to 2002. Fertil Steril. 2007;87:303–9.PubMed
196.
Lass A, Ellenbogen A, Croucher C, Trew G, Margara R, Becattini C, et al. Effect of salpingectomy on ovarian response to superovulation in an in vitro fertilization-embryo transfer program. Fertil Steril. 1998;70:1035–8.PubMed
197.
Sezik M, Ozkaya O, Demir F, Sezik HT, Kaya H. Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow. J Obstet Gynaecol Res. 2007;33:863–9.PubMed
198.
Dar P, Sachs GS, Strassburger D, Bukovsky I, Arieli S. Ovarian function before and after salpingectomy in artificial reproductive technology patients. Hum Reprod. 2000;15:142–4.PubMed
199.
Tal J, Paltieli Y, Korobotchka R, Ziskind G, Eibschitz I, Ohel G. Ovarian response to gonadotropin stimulation in repeated IVF cycles after unilateral salpingectomy. J Assist Reprod Genet. 2002;19:451–5.PubMedCentralPubMed
200.
Gelbaya TA, Nardo LG, Fitzgerald CT, Horne G, Brison DR, Lieberman BA. Ovarian response to gonadotropins after laparoscopic salpingectomy or the division of fallopian tubes for hydrosalpinges. Fertil Steril. 2006;85:1464–8.PubMed
201.
Orvieto R, Saar-Ryss B, Morgante G, Gemer O, Anteby EY, Meltcer S. Does salpingectomy affect the ipsilateral ovarian response to gonadotropin during in vitro fertilization-embryo transfer cycles? Fertil Steril. 2011;95:1842–4.PubMed
202.
Almog B, Wagman I, Bibi G, Raz Y, Azem F, Groutz A, et al. Effects of salpingectomy on ovarian response in controlled ovarian hyperstimulation for in vitro fertilization: a reappraisal. Fertil Steril. 2011;95:2474–6.PubMed
203.
Xi W, Gong F, Tang Y, Zhang H, Lu G. Ovarian response to gonadotropins after laparoscopic salpingectomy for ectopic pregnancy. Int J Gynaecol Obstet. 2012;116:93–6.PubMed
204.
Lin YJ, Ou YC, Huang FJ, Lin PY, Kung FT, Lan KC. Ovarian response to gonadotropins in patients with tubal factor infertility: salpingectomy versus nonsalpingectomy. J Minim Invasive Gynecol. 2013;20:637–41.PubMed
205.
Ni L, Sadiq S, Mao Y, Cui Y, Wang W, Liu J. Influence of various tubal surgeries to serum antimullerian hormone level and outcome of the subsequent IVF-ET treatment. Gynecol Endocrinol. 2013;29:345–9.PubMed
206.
Wiser A, Gilbert A, Nahum R, Orvieto R, Haas J, Hourvitz A, et al. Effects of treatment of ectopic pregnancy with methotrexate or salpingectomy in the subsequent IVF cycle. Reprod Biomed Online. 2013;26:449–53.PubMed
207.
Ye XP, Yang YZ, Sun XX. A retrospective analysis of the effect of salpingectomy on serum antiMullerian hormone level and ovarian reserve. Am J Obstet Gynecol. 2015;212:53. e1-10.PubMed
208.
Hendricks MS, Chin H, Loh SF. Treatment outcome of women with a single ovary undergoing in vitro fertilisation cycles. Singapore Med J. 2010;51:698–701.PubMed
209.
Khalifa E, Toner JP, Muasher SJ, Acosta AA. Significance of basal follicle-stimulating hormone levels in women with one ovary in a program of in vitro fertilization. Fertil Steril. 1992;57:835–9.PubMed
210.
Nargund G, Bromhan D. Comparison of endocrinological and clinical profiles and outcome of IVF cycles in patients with one ovary and two ovaries. J Assist Reprod Genet. 1995;12:458–60.PubMed
211.
Lass A, Paul M, Margara R, Winston RM. Women with one ovary have decreased response to GnRHa/HMG ovulation protocol in IVF but the same pregnancy rate as women with two ovaries. Hum Reprod. 1997;12:298–300.PubMed
212.
Lass A. The fertility potential of women with a single ovary. Hum Reprod Update. 1999;5:546–50.PubMed
213.
Asimakopoulos B, Simopoulou M, Al-Hasani S, Nikolettos N. Women with one ovary in in-vitro fertilisation. Folia Med (Plovdiv). 2003;45:25–9.
214.
Al-Hasani S, Asimakopoulos B, Nikolettos N, Diedrich K. Comparison of the response to ovarian stimulation between women with one ovary and those with two ovaries, in a program of ICSI/ET. Acta Obstet Gynecol Scand. 2003;82:845–9.PubMed
215.
Khan Z, Gada RP, Tabbaa ZM, Laughlin-Tommaso SK, Jensen JR, Coddington 3rd CC, et al. Unilateral oophorectomy results in compensatory follicular recruitment in the remaining ovary at time of ovarian stimulation for in vitro fertilization. Fertil Steril. 2014;101:722–7.PubMed
216.
Maltaris T, Boehm D, Dittrich R, Seufert R, Koelbl H. Reproduction beyond cancer: a message of hope for young women. Gynecol Oncol. 2006;103:1109–21.PubMed
217.
Stern CJ, Toledo MG, Gook DA, Seymour JF. Fertility preservation in female oncology patients. Aust N Z J Obstet Gynaecol. 2006;46:15–23.PubMed
218.
Orvieto R, Kruchkovich J, Zohav E, Rabinson J, Anteby EY, Meltcer S. Does methotrexate treatment for ectopic pregnancy influence the patient’s performance during a subsequent in vitro fertilization/embryo transfer cycle? Fertil Steril. 2007;88:1685–6.PubMed
219.
Oriol B, Barrio A, Pacheco A, Serna J, Zuzuarregui JL, Garcia-Velasco JA. Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve. Fertil Steril. 2008;90:1579–82.PubMed
220.
McLaren JF, Burney RO, Milki AA, Westphal LM, Dahan MH, Lathi RB. Effect of methotrexate exposure on subsequent fertility in women undergoing controlled ovarian stimulation. Fertil Steril. 2009;92:515–9.PubMed
221.
Boots CE, Gustofson RL, Feinberg EC. Does methotrexate administration for ectopic pregnancy after in vitro fertilization impact ovarian reserve or ovarian responsiveness? Fertil Steril. 2013;100:1590–3.PubMed
222.
Uyar I, Yucel OU, Gezer C, Gulhan I, Karis B, Hanhan HM, et al. Effect of single-dose methotrexate on ovarian reserve in women with ectopic pregnancy. Fertil Steril. 2013;100:1310–3.PubMed
223.
Hill MJ, Cooper JC, Levy G, Alford C, Richter KS, DeCherney AH, et al. Ovarian reserve and subsequent assisted reproduction outcomes after methotrexate therapy for ectopic pregnancy or pregnancy of unknown location. Fertil Steril. 2014;101:413–9.PubMedCentralPubMed
Metadata
Title
Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies
Authors
Bassem Refaat
Elizabeth Dalton
William L Ledger
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2015
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/s12958-015-0025-0

Other articles of this Issue 1/2015

Reproductive Biology and Endocrinology 1/2015 Go to the issue

Research

Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles

Research

Leptin in the canine uterus and placenta: possible implications in pregnancy

Research

Late follicular progesterone to estradiol ratio is not influenced by protocols or gonadotropins used

Research

The impact of thyroid function and thyroid autoimmunity on embryo quality in women with low functional ovarian reserve: a case-control study

Research

Mono-ethylhexyl phthalate stimulates prostaglandin secretion in human placental macrophages and THP-1 cells

Research

Expression of adiponectin, chemerin and visfatin in plasma and different tissues during a laying season in turkeys